0001214659-22-000947.txt : 20220120
0001214659-22-000947.hdr.sgml : 20220120
20220120165728
ACCESSION NUMBER: 0001214659-22-000947
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220119
FILED AS OF DATE: 20220120
DATE AS OF CHANGE: 20220120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cherrington Julie M
CENTRAL INDEX KEY: 0001781315
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 22542945
MAIL ADDRESS:
STREET 1: 9393 TOWNE CENTRE DRIVE
STREET 2: STE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
marketforms-55109.xml
PRIMARY DOCUMENT
X0306
4
2022-01-19
0001576263
Mirati Therapeutics, Inc.
MRTX
0001781315
Cherrington Julie M
C/O MIRATI THERAPEUTICS, INC.
3545 CRAY COURT
SAN DIEGO
CA
92121
true
false
false
false
Common Stock
2022-01-19
4
S
false
1475
116.07
D
2546
D
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2021.
/s/ Vickie Reed, Attorney-in-Fact
2022-01-20